CGEM
Price
$12.23
Change
+$0.38 (+3.21%)
Updated
Feb 6 closing price
Capitalization
722.5M
24 days until earnings call
Intraday BUY SELL Signals
IPSC
Price
$1.70
Change
+$0.03 (+1.80%)
Updated
Feb 6 closing price
Capitalization
150.34M
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEM vs IPSC

Header iconCGEM vs IPSC Comparison
Open Charts CGEM vs IPSCBanner chart's image
Cullinan Therapeutics
Price$12.23
Change+$0.38 (+3.21%)
Volume$420.2K
Capitalization722.5M
Century Therapeutics
Price$1.70
Change+$0.03 (+1.80%)
Volume$1.57M
Capitalization150.34M
CGEM vs IPSC Comparison Chart in %
CGEM
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGEM vs. IPSC commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (CGEM: $12.23 vs. IPSC: $1.70)
Brand notoriety: CGEM and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 47% vs. IPSC: 75%
Market capitalization -- CGEM: $722.5M vs. IPSC: $150.34M
CGEM [@Biotechnology] is valued at $722.5M. IPSC’s [@Biotechnology] market capitalization is $150.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 2 TA indicator(s) are bullish while IPSC’s TA Score has 3 bullish TA indicator(s).

  • CGEM’s TA Score: 2 bullish, 6 bearish.
  • IPSC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than CGEM.

Price Growth

CGEM (@Biotechnology) experienced а +2.26% price change this week, while IPSC (@Biotechnology) price change was -10.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.92%. For the same industry, the average monthly price growth was -2.54%, and the average quarterly price growth was +26.81%.

Reported Earning Dates

CGEM is expected to report earnings on Mar 05, 2026.

IPSC is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-0.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($723M) has a higher market cap than IPSC($150M). IPSC YTD gains are higher at: 70.889 vs. CGEM (18.164). IPSC has higher annual earnings (EBITDA): -909K vs. CGEM (-241.13M). CGEM has more cash in the bank: 333M vs. IPSC (133M). CGEM has less debt than IPSC: CGEM (1.19M) vs IPSC (45M). IPSC has higher revenues than CGEM: IPSC (113M) vs CGEM (0).
CGEMIPSCCGEM / IPSC
Capitalization723M150M482%
EBITDA-241.13M-909K26,527%
Gain YTD18.16470.88926%
P/E RatioN/AN/A-
Revenue0113M-
Total Cash333M133M250%
Total Debt1.19M45M3%
TECHNICAL ANALYSIS
Technical Analysis
CGEMIPSC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signal:
Gain/Loss:
IPSC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUMIX19.530.66
+3.50%
Fidelity SAI US Momentum Index
TCGRX31.921.03
+3.33%
Thornburg Small/Mid Cap Growth R4
MVEIX12.220.25
+2.09%
Monteagle Select Value I
AFVZX24.430.50
+2.09%
Applied Finance Select Institutional
DIFHX12.820.07
+0.55%
MFS Diversified Income R6

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been closely correlated with TERN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGEM jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+3.21%
TERN - CGEM
80%
Closely correlated
+6.88%
IPSC - CGEM
77%
Closely correlated
+1.80%
ATOS - CGEM
77%
Closely correlated
+0.19%
RVMD - CGEM
77%
Closely correlated
+1.39%
ERAS - CGEM
77%
Closely correlated
+3.45%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been closely correlated with ACET. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if IPSC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+1.80%
ACET - IPSC
88%
Closely correlated
+9.16%
ATOS - IPSC
86%
Closely correlated
+0.19%
TERN - IPSC
85%
Closely correlated
+6.88%
STRO - IPSC
85%
Closely correlated
+6.30%
ERAS - IPSC
85%
Closely correlated
+3.45%
More